Prenatal diagnosis in congenital contractural arachnodactyly

Susan Belleh, Linda Spooner, Judith Allanson, Maurice Godfrey

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Congenital contractural arachnodactyly (CCA) is a heritable connective tissue disorder caused by defects in the gene encoding fibrillin-2 (FBN2). People with CCA typically have a marfanoid habitus, flexion contractures, severe kyphoscoliosis, abnormal pinnae, and muscular hypoplasia. Because of the relative infrequency of the syndrome and its generally mild to moderate severity, prenatal diagnosis had not previously been sought. Here we report prenatal diagnosis in a family with CCA. Because the course of the disease in the proband was rather severe, she had requested genetic counseling as early as age 17. She delayed childbearing until prenatal diagnosis for CCA became possible. This decision was supported by her mother and later her husband. Because she shared the same genotype with her husband, genetic linkage analysis of this family did not alter the a priori 50% risk of having an affected child. The possibility of unambiguously ascertaining the affected status of a fetus homozygous for the tested FBN2 marker was sufficient for the family to pursue prenatal diagnosis. This case strongly points to the importance of informed decisions now that genetic testing is becoming commonplace.

Original languageEnglish (US)
Pages (from-to)293-296
Number of pages4
JournalGenetic Testing
Volume1
Issue number4
StatePublished - Dec 1 1998

Fingerprint

Prenatal Diagnosis
Spouses
Reproductive Behavior
Genetic Linkage
Genetic Counseling
Genetic Testing
Contracture
Connective Tissue
Fetus
Genotype
Mothers
Congenital contractural arachnodactyly
Genes
Fibrillin-2

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Belleh, S., Spooner, L., Allanson, J., & Godfrey, M. (1998). Prenatal diagnosis in congenital contractural arachnodactyly. Genetic Testing, 1(4), 293-296.

Prenatal diagnosis in congenital contractural arachnodactyly. / Belleh, Susan; Spooner, Linda; Allanson, Judith; Godfrey, Maurice.

In: Genetic Testing, Vol. 1, No. 4, 01.12.1998, p. 293-296.

Research output: Contribution to journalArticle

Belleh, S, Spooner, L, Allanson, J & Godfrey, M 1998, 'Prenatal diagnosis in congenital contractural arachnodactyly', Genetic Testing, vol. 1, no. 4, pp. 293-296.
Belleh S, Spooner L, Allanson J, Godfrey M. Prenatal diagnosis in congenital contractural arachnodactyly. Genetic Testing. 1998 Dec 1;1(4):293-296.
Belleh, Susan ; Spooner, Linda ; Allanson, Judith ; Godfrey, Maurice. / Prenatal diagnosis in congenital contractural arachnodactyly. In: Genetic Testing. 1998 ; Vol. 1, No. 4. pp. 293-296.
@article{f460b12cb7154ad2b9c569a31fb5c2b6,
title = "Prenatal diagnosis in congenital contractural arachnodactyly",
abstract = "Congenital contractural arachnodactyly (CCA) is a heritable connective tissue disorder caused by defects in the gene encoding fibrillin-2 (FBN2). People with CCA typically have a marfanoid habitus, flexion contractures, severe kyphoscoliosis, abnormal pinnae, and muscular hypoplasia. Because of the relative infrequency of the syndrome and its generally mild to moderate severity, prenatal diagnosis had not previously been sought. Here we report prenatal diagnosis in a family with CCA. Because the course of the disease in the proband was rather severe, she had requested genetic counseling as early as age 17. She delayed childbearing until prenatal diagnosis for CCA became possible. This decision was supported by her mother and later her husband. Because she shared the same genotype with her husband, genetic linkage analysis of this family did not alter the a priori 50{\%} risk of having an affected child. The possibility of unambiguously ascertaining the affected status of a fetus homozygous for the tested FBN2 marker was sufficient for the family to pursue prenatal diagnosis. This case strongly points to the importance of informed decisions now that genetic testing is becoming commonplace.",
author = "Susan Belleh and Linda Spooner and Judith Allanson and Maurice Godfrey",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "1",
pages = "293--296",
journal = "Genetic Testing and Molecular Biomarkers",
issn = "1945-0265",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Prenatal diagnosis in congenital contractural arachnodactyly

AU - Belleh, Susan

AU - Spooner, Linda

AU - Allanson, Judith

AU - Godfrey, Maurice

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Congenital contractural arachnodactyly (CCA) is a heritable connective tissue disorder caused by defects in the gene encoding fibrillin-2 (FBN2). People with CCA typically have a marfanoid habitus, flexion contractures, severe kyphoscoliosis, abnormal pinnae, and muscular hypoplasia. Because of the relative infrequency of the syndrome and its generally mild to moderate severity, prenatal diagnosis had not previously been sought. Here we report prenatal diagnosis in a family with CCA. Because the course of the disease in the proband was rather severe, she had requested genetic counseling as early as age 17. She delayed childbearing until prenatal diagnosis for CCA became possible. This decision was supported by her mother and later her husband. Because she shared the same genotype with her husband, genetic linkage analysis of this family did not alter the a priori 50% risk of having an affected child. The possibility of unambiguously ascertaining the affected status of a fetus homozygous for the tested FBN2 marker was sufficient for the family to pursue prenatal diagnosis. This case strongly points to the importance of informed decisions now that genetic testing is becoming commonplace.

AB - Congenital contractural arachnodactyly (CCA) is a heritable connective tissue disorder caused by defects in the gene encoding fibrillin-2 (FBN2). People with CCA typically have a marfanoid habitus, flexion contractures, severe kyphoscoliosis, abnormal pinnae, and muscular hypoplasia. Because of the relative infrequency of the syndrome and its generally mild to moderate severity, prenatal diagnosis had not previously been sought. Here we report prenatal diagnosis in a family with CCA. Because the course of the disease in the proband was rather severe, she had requested genetic counseling as early as age 17. She delayed childbearing until prenatal diagnosis for CCA became possible. This decision was supported by her mother and later her husband. Because she shared the same genotype with her husband, genetic linkage analysis of this family did not alter the a priori 50% risk of having an affected child. The possibility of unambiguously ascertaining the affected status of a fetus homozygous for the tested FBN2 marker was sufficient for the family to pursue prenatal diagnosis. This case strongly points to the importance of informed decisions now that genetic testing is becoming commonplace.

UR - http://www.scopus.com/inward/record.url?scp=0031292243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031292243&partnerID=8YFLogxK

M3 - Article

C2 - 10464661

AN - SCOPUS:0031292243

VL - 1

SP - 293

EP - 296

JO - Genetic Testing and Molecular Biomarkers

JF - Genetic Testing and Molecular Biomarkers

SN - 1945-0265

IS - 4

ER -